Harmonizing pharmaceutical product labeling (i.e., using identical labeling across multiple countries) can create time and cost efficiencies that benefit stakeholders across the value chain. Under the LEAP Initiative, Impact RH360, WCG Cares, and FHI 360 developed a strategy to implement harmonized labeling for the hormonal IUD, Avibela. The project team is disseminating the learnings from this project to enable other suppliers to implement harmonized labeling for their products, if desired.

This resource brief offers guidance on the output indicator couple years of protection, including how to update existing methods and add new methods.

This resource library has been developed to provide comprehensive information on DMPA-SC evidence, country introduction experiences, service delivery and advocacy tools, and more for global- and country-level family planning implementers and decision-makers. This site is hosted by the DMPA-SC Access Collaborative, an initiative led by PATH in partnership with JSI, Inc. The Access Collaborative provides data-driven technical assistance, coordination, resources, and tools to ensure that women have increased access to DMPA-SC self-injection as part of an expanded range of contraceptive methods, delivered through informed choice programming. The Access Collaborative also facilitates learning exchange and dissemination within and among countries by sharing results and lessons learned, encouraging and facilitating discussion, troubleshooting challenges, and accelerating the adoption of best practices. This resource library was developed to help further those efforts.

HIP slide decks are adaptations of the HIP briefs on family planning and reproductive health and are intended to make it easier to present specific HIPs to various audiences. These PowerPoint slides are downloadable, include speaking notes for the presenter, and are fully editable to adapt to your needs.

This resource provides accurate and practical guidance on contraceptive methods. Click on the link to explore permanent, long-acting, short-acting, natural, and emergency contraceptive methods. A PDF of the physical poster is also available for download.

The Reproductive Health Access Project (RHAP) is a US-based national nonprofit organization that works directly with primary care providers, helping them integrate abortion, contraception, and miscarriage care into their practices so that everyone can receive this essential health care from their own primary care clinicians.

This database serves academic institutions, government organizations and R&D units across a variety of industries on health sciences, including pharmacology and toxicology, life sciences, physical sciences, and social sciences.

Shaping Equitable Market Access for Reproductive Health (SEMA Reproductive Health) is a new, innovative partnership designed to build healthier, more equitable, and more resilient SRH markets so that women, girls, and people everywhere can control their bodies and futures. The partnership involves countries, global organizations, and the private sector to align and strengthen market shaping efforts through three main activity areas.

This birth control chart provides high-level information about different birth control options. It is meant for educational purposes for the general public. This chart is not meant to be a complete list of all available birth control options. Talk to your healthcare provider about the best birth control choice for you.

The Family Planning and Reproductive Health Indicators Database, housed on the Data for Impact website, provides a comprehensive listing of the most widely used indicators for evaluating family planning and reproductive health programs in developing countries. The database contains definitions, data requirements, data sources, purposes, and issues for core indicators along with links to other websites and documents containing additional family planning and reproductive health indicators.

The LactMed® database contains information on drugs and other chemicals to which breastfeeding mothers may be exposed. It includes information on the levels of such substances in breast milk and infant blood, and the possible adverse effects in the nursing infant. Suggested therapeutic alternatives to those drugs are provided, where appropriate.

This database, funded by funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, is a curation of public databases for the purpose of providing a list of human reproductive system/tissue specific contraceptive targets for investigators working in the field. The goal of CITDBase is not only to identity potential contraceptive targets but, equally important, to foster collaborative efforts between the investigators from different areas of contraceptive and infertility research.

This report from Policy Cures Research presents the diverse sexual and reproductive health (SRH) R&D funding landscape and highlights a broad spectrum of investment in 2018, totaling $1.7 billion. Based on responses from governments, non-profits, foundations and industry, the 2020 G-FINDER SRH report provides the most up-to-date comprehensive look at the R&D landscape for SRH health issues that disproportionately affect people in low- and middle-income countries (LMICs).

A podcast from Male Contraceptive Initiative, produced by Logan Nickels and Kevin Shane. Intended asks the question – If nearly half of all pregnancies are still unintended, why don’t we have more male birth control options? Unraveled over the course of 8 parts, Intended brings scientists, historians, and couples together to understand the life of The Pill for men in an immersive audio exploration.

This interactive tool provides an innnovative model for estimating impact of removing injectables from the contraceptive method mix.

The American Society for Reproductive Medicine (ASRM) is a non-profit organization whose members must demonstrate the high ethical principles of the medical profession, evince an interest in infertility, reproductive medicine and biology, and adhere to the objectives of the Society. ASRM's vision is to be the nationally and internationally recognized leader for multidisciplinary information, education, advocacy and standards in the field of reproductive medicine.

The Association of Clinical Research Professionals (ACRP) supports clinical research professionals through membership, training and development, and certification. Founded in 1976, ACRP is a US-based non-profit organization with more than 13,000 members who work in clinical research in more than 70 countries.

The Endocrine Society is an organization devoted to research on hormones and the clinical practice of endocrinology. It is an international body whose membership represents medicine, molecular and cellular biology, biochemistry, physiology, genetics, immunology, education, industry, and allied health fields.

The mission of the Society for Reproductive Investigation (SRI) is to advance reproductive and women's health care through outstanding basic, translational, and clinical science and by training and mentoring future generations of investigators. SRI members conduct basic, translational and clinical investigation in the reproductive sciences and women’s health. Areas of focus included obstetrics, perinatology, reproductive genetics, gynecology and more.

The Society for the Study of Reproduction (SSR) promotes the study of reproduction by fostering interdisciplinary communication among scientists, holding conferences, and publishing meritorious studies. The SSR is an association of scientists and physicians, from 50 countries around the world, interested in research on reproduction.